Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Raw Materials (2016 - 2025)

Historic Raw Materials for HUTCHMED (China) (HCM) over the last 10 years, with Q4 2024 value amounting to $24.3 million.

  • HUTCHMED (China)'s Raw Materials fell 909.12% to $24.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $24.3 million, marking a year-over-year decrease of 909.12%. This contributed to the annual value of $24.3 million for FY2024, which is 909.12% down from last year.
  • According to the latest figures from Q4 2024, HUTCHMED (China)'s Raw Materials is $24.3 million, which was down 909.12% from $26.8 million recorded in Q4 2023.
  • HUTCHMED (China)'s 5-year Raw Materials high stood at $27.4 million for Q4 2022, and its period low was $4.5 million during Q4 2020.
  • For the 5-year period, HUTCHMED (China)'s Raw Materials averaged around $19.8 million, with its median value being $24.3 million (2024).
  • Its Raw Materials has fluctuated over the past 5 years, first surged by 25177.7% in 2021, then plummeted by 909.12% in 2024.
  • Quarter analysis of 5 years shows HUTCHMED (China)'s Raw Materials stood at $4.5 million in 2020, then skyrocketed by 251.78% to $15.8 million in 2021, then surged by 72.96% to $27.4 million in 2022, then dropped by 2.22% to $26.8 million in 2023, then dropped by 9.09% to $24.3 million in 2024.
  • Its Raw Materials stands at $24.3 million for Q4 2024, versus $26.8 million for Q4 2023 and $27.4 million for Q4 2022.